Home » Stocks » EDAP

EDAP TMS S.A. (EDAP)

Stock Price: $6.49 USD -0.20 (-2.99%)
Updated May 10, 2021 4:00 PM EDT - Market closed
Pre-market: $6.20 -0.29 (-4.47%) May 11, 8:31 AM
Market Cap 216.42M
Revenue (ttm) 50.81M
Net Income (ttm) -2.08M
Shares Out 33.35M
EPS (ttm) -0.07
PE Ratio n/a
Forward PE 22.27
Dividend n/a
Dividend Yield n/a
Trading Day May 10
Last Price $6.49
Previous Close $6.69
Change ($) -0.20
Change (%) -2.99%
Day's Open 6.74
Day's Range 6.31 - 6.85
Day's Volume 251,080
52-Week Range 2.00 - 10.68

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Company to host conference call and webcast on Wednesday , May 12 at 8:30 am EDT

1 week ago - GlobeNewsWire

LYON, France, April 23, 2021 -- EDAP TMS S.A. (NASDAQ: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced that the price of its offering of American Depositary Shares (“...

2 weeks ago - GlobeNewsWire

LYON, France, April 22, 2021 -- EDAP TMS S.A. (NASDAQ: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today the launch of a follow-on public offering of its American...

2 weeks ago - GlobeNewsWire

Shares of Edap TMS (NASDAQ:EDAP) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 175.00% over the past year to $0.03, which missed the ...

1 month ago - Benzinga

LYON, France, March 30, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today unaudited financial results for the fourth quarter of 2020 ...

1 month ago - GlobeNewsWire

EDAP TMS S.A. (EDAP) was a big mover last session on higher-than-average trading volume.

1 month ago - Zacks Investment Research

Edap TMS (NASDAQ:EDAP) releases its next round of earnings this Tuesday, March 30. Here is Benzinga's essential guide to Edap TMS's Q4 earnings report.

1 month ago - Benzinga

EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, announces today that the company has selected Medical Technology Partners (MTP) and Argenta Advisors, two...

2 months ago - GlobeNewsWire

LYON, France, January 19, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, today announced that Marc Oczachowski, President and CEO, will particip...

3 months ago - GlobeNewsWire

LYON, France, January 14, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, announced today positive 24 month interim results from the “HIFI” study...

3 months ago - GlobeNewsWire

EDAP TMS (EDAP) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

3 months ago - Zacks Investment Research

Recaps progress made in 2020 notwithstanding the ongoing COVID-19 pandemic and previews anticipated 2021 milestones

4 months ago - GlobeNewsWire

LYON, France, January 5, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, today announced that it will participate in the 10th Annual LifeSci Part...

4 months ago - GlobeNewsWire

LYON, France, December 30, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy- based therapies, announced today two new Focal One sales to leading U.S. healthcare in...

4 months ago - GlobeNewsWire

Final rules establish, for the first time, a Category 1 CPT code and reimbursement to physicians performing ablation of malignant prostate tissue with HIFU in the US

5 months ago - GlobeNewsWire

EDAP TMS S.A. (EDAP) CEO Marc Oczachowski on Q3 2020 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

Shares of Edap TMS (NASDAQ:EDAP) were flat after the company reported Q3 results. Quarterly Results Earnings per share decreased 233.33% over the past year to ($0.04), which missed the estimate of ($0.02).

5 months ago - Benzinga

 Generated strongest total revenue quarter of 2020

5 months ago - GlobeNewsWire

LYON, France, November 17, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, announced today that the company has signed an exclusive distribution ...

5 months ago - GlobeNewsWire

LYON, France, November 10, 2020 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that management will be presenting at the Jefferies Virtual London Hea...

6 months ago - GlobeNewsWire

Company to host conference call and webcast on Thursday, November 19 at 8:30 am EDT

6 months ago - GlobeNewsWire

Knifeless Surgery: Prospects And Competition For EDAP

6 months ago - Seeking Alpha

As of late, it has definitely been a great time to be an investor in EDAP TMS.

7 months ago - Zacks Investment Research

The company offers an innovative device that produces non-invasive HIFA treatment for prostate cancer with other applications to follow.

7 months ago - Seeking Alpha

Call to be Held Tuesday, September 22nd @ 8am Eastern Time

7 months ago - GlobeNewsWire

As of late, it has definitely been a great time to be an investor EDAP TMS.

8 months ago - Zacks Investment Research

LYON, France, September 9, 2020 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that management will be presenting at the HC Wainwright Virtual 22nd A...

8 months ago - GlobeNewsWire

EDAP TMS S.A. (EDAP) CEO Marc Oczachowski on Q2 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

LYON, France, August 26, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), the global leader in robotic energy based therapies, announced today financial results for the second quarter of 2020 and pro...

8 months ago - GlobeNewsWire

LYON, France, August 25, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that the company has received approval from French healt...

8 months ago - GlobeNewsWire

Company to host conference call and webcast on Thursday, August 27 at 8:30 am EDT

8 months ago - GlobeNewsWire

 Studies conducted at the University of Southern California and University of Miami represent the first U.S. publications detailing successful partial-gland ablation using high intensity focused ultraso...

8 months ago - GlobeNewsWire

EDAP TMS (EDAP) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

9 months ago - Zacks Investment Research

LYON, France, July 15, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today provided an update on recent sales successes that occurred during th...

9 months ago - GlobeNewsWire

 LYON, France, June 30, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, announced today that veteran medical technology executive Marie Meynadier...

10 months ago - GlobeNewsWire

LYON, France, May 28, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, announced today the appointment of Frank Van Hyfte as Vice President of Glo...

11 months ago - GlobeNewsWire

EDAP Shares Are Still A Steal, But The Pandemic Could Be A Wrench

11 months ago - Seeking Alpha

EDAP TMS S.A. (EDAP) CEO Marc Oczachowski on Q1 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

LYON, France, May 13, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), the global leader in robotic energy based therapies, announced today financial results for the first quarter of 2020 and provide...

11 months ago - GlobeNewsWire

LYON, France, May 12, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, announced today that the company has signed an exclusive worldwide distribu...

11 months ago - GlobeNewsWire

EDAP TMS S.A. (EDAP) CEO Marc Oczachowski on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

LYON, France, March 30, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, announced today financial results for the fourth quarter and full year of...

1 year ago - GlobeNewsWire

LYON, France, March 17, 2020 – EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today issued the following letter to shareholders:  

1 year ago - GlobeNewsWire

LYON, France, February 18, 2020 – EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that the company recently showcased its Focal One high ...

1 year ago - GlobeNewsWire

EDAP Announces Sale of Robotic Focal One® HIFU Device to University of Miami

1 year ago - GlobeNewsWire

Recaps significant progress made in 2019 and previews expectations for accelerating global growth in 2020

1 year ago - GlobeNewsWire

Study confirms feasibility of using Focal One HIFU to treat rectal endometriosis

1 year ago - GlobeNewsWire

LYON, France, November 26, 2019 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in therapeutic ultrasound, announced today that the first Focal One® treatment was performed at Farrer Pa...

1 year ago - GlobeNewsWire

EDAP TMS S.A. (EDAP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

1 year ago - Zacks Investment Research

About EDAP

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three divisions: High Intensity Focused Ultrasound (HIFU); Extracorporeal ShockWave Lithotripsy (ESWL); and Distribution. The HIFU division develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinic... [Read more...]

Industry
Medical Devices
IPO Date
Jul 31, 1997
Stock Exchange
NASDAQ
Ticker Symbol
EDAP
Full Company Profile

Financial Performance

Financial numbers in millions EUR.
Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for EDAP TMS S.A. stock is "Buy." The 12-month stock price forecast is 13.43, which is an increase of 106.93% from the latest price.

Price Target
$13.43
(106.93% upside)
Analyst Consensus: Buy